NCT00736749 Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
| NCT ID | NCT00736749 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Oncology Group |
| Condition | Hematopoietic Cell Transplantation Recipient |
| Study Type | OBSERVATIONAL |
| Enrollment | 25,000 participants |
| Start Date | 2008-07-17 |
| Primary Completion | 2100-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25,000 participants in total. It began in 2008-07-17 with a primary completion date of 2100-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This clinical trial keeps track of and collects follow-up information from patients who are currently enrolled on or have participated in a Children's Oncology Group study. Developing a way to keep track of patients who have participated in Children's Oncology Group studies may allow doctors learn more about the long-term effects of cancer treatment and help them reduce problems related to treatment and improve patient quality of life.
Eligibility Criteria
Inclusion Criteria: * The patient must reside in the U.S. on the date of enrollment to ALTE05N1 * All patients and/or their parents or legal guardians must sign a written informed consent * All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met
Contact & Investigator
Smita Bhatia
PRINCIPAL INVESTIGATOR
Children's Oncology Group
Frequently Asked Questions
Who can join the NCT00736749 clinical trial?
This trial is open to participants of all sexes, studying Hematopoietic Cell Transplantation Recipient. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT00736749 currently recruiting?
Yes, NCT00736749 is actively recruiting participants. Visit ClinicalTrials.gov or contact Children's Oncology Group to inquire about joining.
Where is the NCT00736749 trial being conducted?
This trial is being conducted at Birmingham, United States, Birmingham, United States, Mobile, United States, Phoenix, United States and 11 additional locations.
Who is sponsoring the NCT00736749 clinical trial?
NCT00736749 is sponsored by Children's Oncology Group. The principal investigator is Smita Bhatia at Children's Oncology Group. The trial plans to enroll 25,000 participants.